INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Observational study / 2015

Circulating metabolites, including lipids, energy compounds, and trimethylamine oxide, were associated with aggressive prostate cancer risk.

Within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, researchers analyzed fasting serum collected up to 20 years prior to diagnosis in 200 prostate cancer cases (100 aggressive) and 200 matched controls. Energy and lipid metabolites showed strong inverse associations with aggressive cancer (chemical class p = 0.018 and p = 0.041), with inositol-1-phosphate showing the strongest inverse association (OR = 0.56, 95% CI 0.39-0.81, p = 0.002). Alpha-ketoglutarate and citrate were also inversely linked to aggressive disease (each OR = 0.69, p = 0.02), whereas elevated thyroxine (OR = 1.65, 95% CI 1.08-2.54) and trimethylamine oxide (OR = 1.36, 95% CI 1.02-1.81) were associated with increased risk. Findings remained consistent after adjustment for serum PSA.

Shows an association, not proof of cause and effect.

Study type
Nested matched case-control study
Who was studied
400 men (200 prostate cancer cases [100 aggressive] and 200 matched controls) from the ATBC Study
What was measured
Risk of prostate cancer (including aggressive prostate cancer)

THE PAPER

Metabolomic analysis of prostate cancer risk in a prospective cohort: The alpha-tocopherol, beta-carotene cancer prevention (ATBC) study.

Mondul AM, Moore SC, Weinstein SJ, Karoly ED, Sampson JN, Albanes D. Int J Cancer, 2015.

PubMed 25904191 ↗DOI 10.1002/ijc.29576 ↗

Cancer

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.